1.96
price up icon4.81%   0.09
after-market Dopo l'orario di chiusura: 1.97 0.01 +0.51%
loading

Adial Pharmaceuticals Inc Azioni (ADIL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
6.88%
1.8854
1.7641 - 2.2673 1.9407
Operating Income/Loss
6.88%
-1.8854
-1.7641 - -2.2673 -1.9407
Nonoperating Income/Loss
274.61%
-0.1108
-0.0296 - 0.0385 -0.1301
Income/Loss Before Equity Method Investments
7.34%
-1.8428
-1.7167 - -2.0657 -1.962
Income/Loss From Equity Method Investments
99.41%
-0.1534
-0.0769 - -0.1631 -0.1088
Income/Loss From Continuing Operations Before Tax
11.29%
-1.9962
-1.7937 -1.9586 -2.2288 -2.0708
Income/Loss From Continuing Operations After Tax
11.29%
-1.9962
-1.7937 -1.9586 -2.2288 -2.0708
Net Income/Loss
11.29%
-1.9962
-1.7937 -1.9586 -2.2288 -2.0708
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
156.39%
-12.50
22.17 - - -
Diluted Average Shares
156.39%
-12.50
22.17 - 6.5398 0.5213
Basic Earnings Per Share
14,250%
-11.48
-0.08 - -0.34 -0.15
Diluted Earnings Per Share
14,250%
-11.48
-0.08 - -0.34 -0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):